REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02/16/2026
Back to search
Official data from USPTO
LYSOVANT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
02/17/2026
Trademark type
Combined
Nice classes
5, 42, 44
Filing date
02/24/2020
Registration date
02/16/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/16/2021
Last transaction
02/17/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
3
Owner type
99
Owner location
Basel, CH
Examiner
KNIGHT, TROY FRANK
Law office
L70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a design of four bands of shaded circles forming four concentric circles followed by the stylized word "LYSOVANT".
Holders and representatives
Holders
Roivant Sciences GmbH
Representatives
Allison Strickland Ricketts FROSS ZELNICK LEHRMAN & ZISSU, P.C.
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for human use for the treatment of infectious diseases; biologic preparations for medical and therapeutic purposes for the treatment of infectious diseases
Class 42
Scientific and technological servicesmedical researchscientific research and analysis in the fields of pharmaceuticals and biomedicine; pharmaceuticalbiomedical and biological therapeutic research services; scientific research in the fields of pharmaceutical and biologic therapeutic preparationsclinical trials and post-market trials; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticalsbiomedicineclinical trials and post-market trials
Class 44
Providing health and medical information; providing information relating to the diagnosticprophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseasesdisorders and conditions
Publications
History of USPTO decisions and trademark events.
16 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/16/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/01/2020
PUBO
PUBLISHED FOR OPPOSITION
12/01/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/11/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/28/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/28/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/28/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/28/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/22/2020
GNRT
NON-FINAL ACTION E-MAILED
05/22/2020
CNRT
NON-FINAL ACTION WRITTEN
05/22/2020
DOCK
ASSIGNED TO EXAMINER
05/12/2020
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
02/28/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/27/2020
NWAP
NEW APPLICATION ENTERED
02/27/2020
Continuous trademark protection
Get notified about every new filing that threatens LYSOVANT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.